DE69834655D1 - Pharmazeutische suspension mit nevirapine hemihydrat - Google Patents

Pharmazeutische suspension mit nevirapine hemihydrat

Info

Publication number
DE69834655D1
DE69834655D1 DE69834655T DE69834655T DE69834655D1 DE 69834655 D1 DE69834655 D1 DE 69834655D1 DE 69834655 T DE69834655 T DE 69834655T DE 69834655 T DE69834655 T DE 69834655T DE 69834655 D1 DE69834655 D1 DE 69834655D1
Authority
DE
Germany
Prior art keywords
pharmaceutical suspension
nevirapine hemihydrate
nevirapine
hemihydrate
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834655T
Other languages
English (en)
Other versions
DE69834655T2 (de
Inventor
Georg Grozinger
A Hawi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69834655(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69834655D1 publication Critical patent/DE69834655D1/de
Publication of DE69834655T2 publication Critical patent/DE69834655T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69834655T 1997-08-25 1998-08-11 Pharmazeutische suspension mit nevirapine hemihydrat Expired - Lifetime DE69834655T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25
US56803P 1997-08-25
PCT/US1998/016581 WO1999009990A1 (en) 1997-08-25 1998-08-11 Pharmaceutical suspension comprising nevirapine hemihydrate

Publications (2)

Publication Number Publication Date
DE69834655D1 true DE69834655D1 (de) 2006-06-29
DE69834655T2 DE69834655T2 (de) 2006-12-14

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834655T Expired - Lifetime DE69834655T2 (de) 1997-08-25 1998-08-11 Pharmazeutische suspension mit nevirapine hemihydrat

Country Status (38)

Country Link
US (2) US6172059B1 (de)
EP (1) EP1019058B1 (de)
JP (1) JP3472261B2 (de)
KR (1) KR100426516B1 (de)
CN (1) CN1197578C (de)
AR (2) AR016869A1 (de)
AT (1) ATE326971T1 (de)
AU (1) AU742761B2 (de)
BG (1) BG64337B1 (de)
BR (1) BR9811994B1 (de)
CA (1) CA2301646C (de)
CL (1) CL2008003111A1 (de)
CO (1) CO4970742A1 (de)
CY (1) CY1105228T1 (de)
CZ (1) CZ290667B6 (de)
DE (1) DE69834655T2 (de)
DK (1) DK1019058T3 (de)
EG (1) EG24075A (de)
ES (1) ES2265666T3 (de)
HK (1) HK1027975A1 (de)
HR (1) HRP980461B1 (de)
HU (1) HU226063B1 (de)
ID (1) ID21650A (de)
IL (1) IL134185A (de)
MY (1) MY122272A (de)
NO (1) NO326226B1 (de)
NZ (1) NZ503414A (de)
PE (1) PE105799A1 (de)
PL (1) PL192361B1 (de)
PT (1) PT1019058E (de)
RS (1) RS49808B (de)
RU (1) RU2196584C2 (de)
SA (1) SA98190680B1 (de)
TR (1) TR200000490T2 (de)
TW (1) TW450812B (de)
UA (1) UA44370C2 (de)
WO (1) WO1999009990A1 (de)
ZA (1) ZA987623B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
EP1504040A1 (de) * 2002-04-23 2005-02-09 Boehringer Ingelheim Pharmaceuticals Inc. Verfahrung zur verringerung von organischem restlösungsmittel aus carbomer
KR20080053317A (ko) * 2005-08-31 2008-06-12 씨아이피엘에이 엘티디. 라미부딘, 스타부딘 및 네비라핀을 포함하는 약학적 조합물
US20110082161A1 (en) * 2008-06-30 2011-04-07 Lieven Elvire Colette Baert Powders for reconstitution
BR112012011095A2 (pt) * 2009-11-10 2015-10-06 Univ Northwest método para aumentar a solubilidade de uma composição inibidora de transcriptase
DE112010004862T5 (de) * 2009-12-17 2012-12-06 North West University Polymorphe Form von Nevirapin und deren Herstellung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
CL2008003111A1 (es) 2009-09-11
KR100426516B1 (ko) 2004-04-13
NO20000906D0 (no) 2000-02-24
CA2301646A1 (en) 1999-03-04
DE69834655T2 (de) 2006-12-14
CY1105228T1 (el) 2010-03-03
RU2196584C2 (ru) 2003-01-20
ID21650A (id) 1999-07-08
SA98190680B1 (ar) 2006-04-04
PT1019058E (pt) 2006-08-31
US6255481B1 (en) 2001-07-03
AU8777198A (en) 1999-03-16
ATE326971T1 (de) 2006-06-15
CO4970742A1 (es) 2000-11-07
PE105799A1 (es) 1999-11-16
HUP0003093A2 (hu) 2001-08-28
HK1027975A1 (en) 2001-02-02
UA44370C2 (uk) 2002-02-15
EP1019058A4 (de) 2004-11-10
US6172059B1 (en) 2001-01-09
DK1019058T3 (da) 2006-06-12
NZ503414A (en) 2002-11-26
ZA987623B (en) 2000-03-22
CA2301646C (en) 2008-11-18
TR200000490T2 (tr) 2000-08-21
MY122272A (en) 2006-04-29
JP3472261B2 (ja) 2003-12-02
JP2001513564A (ja) 2001-09-04
CN1197578C (zh) 2005-04-20
AR016869A1 (es) 2001-08-01
CZ2000694A3 (cs) 2000-09-13
HRP980461B1 (en) 2002-08-31
NO326226B1 (no) 2008-10-20
KR20010023257A (ko) 2001-03-26
EP1019058A1 (de) 2000-07-19
IL134185A (en) 2005-11-20
EP1019058B1 (de) 2006-05-24
PL338828A1 (en) 2000-11-20
BG64337B1 (bg) 2004-10-29
BG104133A (en) 2000-08-31
CZ290667B6 (cs) 2002-09-11
HRP980461A2 (en) 1999-06-30
PL192361B1 (pl) 2006-10-31
AU742761B2 (en) 2002-01-10
IL134185A0 (en) 2001-04-30
ES2265666T3 (es) 2007-02-16
YU9800A (sh) 2001-12-26
WO1999009990A1 (en) 1999-03-04
AR083451A2 (es) 2013-02-27
RS49808B (sr) 2008-08-07
EG24075A (en) 2008-05-11
HU226063B1 (hu) 2008-04-28
NO20000906L (no) 2000-02-24
TW450812B (en) 2001-08-21
CN1268055A (zh) 2000-09-27
BR9811994B1 (pt) 2013-11-19
BR9811994A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
NO20001776L (no) Medikamenter
DE69810612D1 (de) Pharmazeutische Zusammensetzungen mit Plasmaproteinen
EE200000658A (et) CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine
EE04293B1 (et) Stabiilsed lüofiliseeritud ravimvormid
DE59814338D1 (de) 3-heteroxyclyl-substituierte benzoylderivate
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
ATE234078T1 (de) Pharmazeutische omeprazol-formulierung
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
ATE432707T1 (de) Pharmazeutische zubereitung
NO980546D0 (no) Farmasöytiske midler
DE69829254D1 (de) Arzneistoffzubereitung mit kontrollierter Wirkstofffreisetzungsrate
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
DE59908305D1 (de) Pharmazeutische kombinationen mit tramadol
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE69830154D1 (de) Pharmazeutische zusammensetzungen
NO995039L (no) Gastrisk bibeholdt farmasoeytisk preparat
ATE326971T1 (de) Pharmazeutische suspension mit nevirapine hemihydrat
ID25857A (id) Komposisi farmasi
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
DE19681529D2 (de) Pharmazeutische Darreichungsform
NO942228D0 (no) Ipsapiron-legemiddeltilberedning
ID23531A (id) Komposisi farmasi
ATA77096A (de) Pharmazeutische präparation
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
SE9302429D0 (sv) New pharmaceutical preparation ii

Legal Events

Date Code Title Description
8364 No opposition during term of opposition